Anæmi kliniske forsøg i Pennsylvania
7 studier for Anæmi søger deltagere på steder i Pennsylvania.
Byer i Pennsylvania
Officiel studietekst (engelsk)
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
- Thomas Jefferson University, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
- Allegheny Health Network Cancer Institute - West Penn Hospital Location, Pittsburgh
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07623161Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- University of Pennsylvania, Philadelphia
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT05320198A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Thomas Jefferson University, Philadelphia
- Fox Chase Cancer Center, Philadelphia
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT07422480T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
RekruttererFase 1/2
Alder 5 til 40 · Alle køn · Opdateret 13. aug. 2026 · NCT03653338Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients
- Childrens Hospital of Philadelphia, Philadelphia
RekruttererFase 3
Alder 2 til 18 · Alle køn · Opdateret 7. aug. 2026 · NCT06934967Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy
- Fox Chase Cancer Center, Philadelphia
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 22. maj 2026 · NCT05800600Oral Iron in Children With Chronic Kidney Disease
- Children's Hospital of Philadelphia, Philadelphia
RekruttererFase 4
Alder 1 til 21 · Alle køn · Opdateret 11. aug. 2025 · NCT03991169Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.